You are here

George Scangos

Veteran biotech leader George Scangos to step down as Vir CEO

BioPharma Dive

Wed, 01/25/23 - 10:46 pm

Vir Biotchnology

Scangos' Vir Biotechnology to test COVID-19 antibody 'in the summer'

Fierce Biotech

Wed, 03/25/20 - 10:40 am

Vir Biotechnology

Biogen signs on to manufacture clinical supplies for Vir's COVID-19 antibodies

Fierce Pharma

Thu, 03/12/20 - 11:01 pm

Vir Biotechnology

drug manufacturing

Biotechnology trade group taps former Biogen CEO as its coronavirus czar

Reuters

Sat, 02/29/20 - 06:48 pm

With $500M-plus, a buyout and two new billion-dollar pacts, upstart Vir is ready to roll on infectious diseases

Endpoints

Wed, 10/18/17 - 10:08 am

Vir Biotechnology

Scangos left Biogen in style, taking a final $17.7M compensation package for one last, disappointing year

Endpoints

Thu, 04/27/17 - 09:13 am

Ex-Biogen chief George Scangos to spearhead a Gates-backed startup with big plans to fight infectious diseases

Endpoints

Fri, 01/6/17 - 09:45 am

Vir Biotechnology

Here's Why Investors Weren't Excited About Biogen's New CEO

Fortune

Tue, 12/20/16 - 12:46 pm

Michel Vounatsos

Here's Why Biogen Should Buy Ionis Pharmaceuticals

Motley Fool

Sat, 10/29/16 - 01:18 pm

Ionis Pharmaceuticals

Departing Novo chief wins 'best CEO' nod again, and Biogen's grabs laurels, too

Fierce Pharma

Thu, 10/13/16 - 10:56 am

Biogen Needs To Fill Pipeline Or Rethink Strategy

Seeking Alpha

Mon, 07/25/16 - 10:08 am

Biogen (BIIB) Stock Up on CEO Transition, Fueling Sale Speculation

TheStreet.com

Sat, 07/23/16 - 10:28 am

Biogen CEO has 'mixed emotions' as he leaves company after 6 years

CNBC

Thu, 07/21/16 - 09:10 pm

Biogen CEO George Scangos to step down

BioPharma Dive

Thu, 07/21/16 - 09:34 am

Biogen CEO nets $49 million in pay and stock gains in 2015

Bizjournals.com

Sat, 04/16/16 - 03:59 pm

Biogen's CEO Sums Up Everything You Need to Know About the Company in 1 Comment

Motley Fool

Fri, 01/15/16 - 02:34 pm

High drug prices bring forth innovation: Scangos

CNBC

Tue, 01/12/16 - 08:22 am

Biogen's CEO Spending Spree Comes At The Expense Of Shareholders

Seeking Alpha

Sat, 06/13/15 - 09:38 am

Alzheimer's disease

Biogen CEO Transformed Embattled Biotech in Five Short Years

Yahoo/Bloomberg

Sat, 03/21/15 - 10:50 am

[video] Biogen Has Many `Exciting' Drugs in Pipeline: CEO

Bloomberg

Tue, 01/14/14 - 11:55 am

Pages